Table 2.

Analysis of selected studies regarding the duration of rebamipide use.

Duration	Studies
Short (10 d–2 w)	Hahm et al. [27]; Nebiki et al. [28]; Lee et al. [31]; Kim et al. [34]; Dicheva et al. [35]; Andreev et al. [36] (1 arm)
Long (4–12 w)	Saita et al. [26]; Kato et al. [29]; Kimura et al. [30]; Fujioka et al. [32]; Simanenkov et al. [33]; Andreev et al. [36] (2 arms)